The largest database of trusted experimental protocols

Aquasonic 100 ultrasound transmission gel

Manufactured by Parker Laboratories
Sourced in United States

Aquasonic 100 Ultrasound Transmission Gel is a sterile, hypoallergenic, and water-soluble product designed for use in ultrasound procedures. It serves as a medium to facilitate the transmission of ultrasound waves between the transducer and the patient's skin.

Automatically generated - may contain errors

5 protocols using aquasonic 100 ultrasound transmission gel

1

Cross-Sectional Area Assessment of Lower Limb Muscles

Check if the same lab product or an alternative is used in the 5 most similar protocols
Prior to performing the warm-up and 1RM back squat protocol, CSA measurements of the participants’ right vastus lateralis (VL) and biceps femoris (BF) muscles were assessed using a linear probe scanning head with a 3.4–10.8 MHz bandwidth range (LOGIQ P6, GE Healthcare, Wauwatosa, WI, USA). The probe was coated with a water soluble transmission gel (Aquasonic 100 ultrasound transmission gel, Parker Laboratories, Inc., Fairfield, NJ, USA) and positioned on the surface of the skin to provide acoustic contact without depressing the dermal layer to collect an image. The CSA images for the VL and BF were obtained using a sweep of the muscle in the extended field of view mode with the gain set to 50 dB and an image depth to 5 cm. For the VL CSA measurements, participants laid on an athletic training table on their left side with their legs together and relaxed with 15° of knee flexion as measured by a manual goniometer [24 (link)]. For the BF CSA measurements, participants laid in a prone position with their feet hanging off the end of the athletic training table. The anatomical location for all CSA measurements was standardized for all participants. VL CSA was measured at 50% of the distance between the greater trochanter and the lateral condyle of the tibia. BF CSA was measured at 50% of the distance between the ischial tuberosity and the posterior aspect of the fibular head.
+ Open protocol
+ Expand
2

Spleen Vascularization Monitoring

Check if the same lab product or an alternative is used in the 5 most similar protocols
Short and long term blood perfusion of transplanted spleens was confirmed by high resolution ultrasonography using Vevo 2100 system (FujiFilm VisualSonics, Toronto, ON, Canada).CD45.2+ C57BL6/J transplanted recipient mice were anesthetized with isoflurane supplemented with oxygen (2–3 Vol%). Once anesthetized, animals were removed from the induction box and placed in dorsal position on a heated imaging platform and remained anesthetized via a nose cone. Prior to start imaging, the tail vein was catheterized, using a 27-gauge needle connected to a modified P10 tubing catheter, and the anterior abdominal wall was shaved. Aquasonic-100 ultrasound transmission gel (Parker Laboratories, Fairfield, NJ) was applied over the abdominal wall and a 40-MHz imaging transducer was placed longitudinally over the left region of the abdomen. B-mode and color doppler imaging were taken before and after a bolus tail vein injection of 100-μL of microbubbles contrast agent (VEVO non-targeted micromarker microbubbles, FujiFilm VisualSonics) and continue microbubbles injection at a constant rate of 9 μL/min through the duration of spleen imaging.
+ Open protocol
+ Expand
3

Ultrasound Phantom Performance Evaluation

Check if the same lab product or an alternative is used in the 5 most similar protocols
The multipurpose, multi-tissue ultrasound phantom (model 040GSE Computerized Imaging Reference Systems Inc.) was used for performance and quality assurance testing of the phased array (fig. S10). For this phantom, the gel was used to ensure the acoustic coupling (Aquasonic 100 Ultrasound Transmission Gel, Parker Laboratories Inc.). The US-18 fundamental ultrasound phantom (Kyoto Kagaku Co. Ltd.) with an oval shape and curved surface was used for the array imaging on different 3D objects (fig. S11).
+ Open protocol
+ Expand
4

Phantom-based Evaluation of Ultrasound-guided Needle Insertion

Check if the same lab product or an alternative is used in the 5 most similar protocols
A mock procedure was performed with a phantom to qualitatively evaluate the proposed navigation system and its workflow. The phantom was a 2.5 kg bovine liver submerged in 2% agar (010–15815 agar powder, Wako Pure Chemical Industries, Ltd., Osaka, Japan) mixed with 0.25 mM Gd-DTPA in a plastic container, with small pieces of acrylic rods and tubes distributed randomly as targets. A convex probe was used for US imaging. The scan phase acquired a T1 weighted 3D image in the coronal plane with a Spine Matrix Coil using a 3D fast acquisition low flip angle spoiled gradient echo sequence (TR/TE = 8.6/3.86 ms; flip angle = 25°; acquisition matrix = 256×256; field of view (FOV) = 240×240 mm2; slice thickness = 2.5 mm). The preset distance was set to 150 mm to avoid contact between the needle guide and phantom surface during path planning. After path planning, the water-filled rubber bag was placed on the phantom surface with the appropriate amount of gel (Aquasonic 100 Ultrasound Transmission Gel, 250 ml, Parker Laboratories, Inc., Fairfield, NJ) (Fig. 6). The needle guide was moved along the needle path until the US probe had sufficient contact with the rubber bag, and then a 20 cm 14 gauge MRI-compatible needle (Invivo, Gainesville, FL) with a beveled tip was used. We performed the feasibility study five times and recorded the time required for each setup (Fig. 5).
+ Open protocol
+ Expand
5

Evaluation of Adjuvant Effects on Material

Check if the same lab product or an alternative is used in the 5 most similar protocols
Adjuvants selected for study included ultrasound gel (Aquasonic 100 Ultrasound Transmission Gel, Parker Laboratories, Fairfield, NJ USA), foam hand sanitizer (Soft ‘N Sure Hand Sanitizer, 1381-36, Steris Corporation, Mentor, OH USA), and liquid soap (Acute-Kare Healthcare Personnel Handwash, 1206-87, Steris Corporation, Mentor, OH USA). Three grams of each adjuvant was applied to one side of the sample using gloved hands and a side-to-side motion with consistent pressure for 1 min, after which the sample was turned over and the process repeated on the other side. Control samples were treated in a similar fashion with no adjuvant applied. After lamination, samples were randomly assigned to rest for 5, 10, or 15 min prior to testing.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!